AMAR PATEL: Open Payments
NPI 1104316256 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 110 payments from 22 companies in 2025. Trend: 2023 $1,260 · 2024 $1,438 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $403 |
| Lilly USA, LLC | 8 | $254 |
| PFIZER INC. | 13 | $245 |
| AstraZeneca Pharmaceuticals LP | 10 | $216 |
| ABBVIE INC. | 17 | $199 |
| GlaxoSmithKline, LLC. | 7 | $154 |
| Eisai Inc. | 9 | $146 |
| Dexcom, Inc. | 1 | $138 |
| Novo Nordisk Inc | 5 | $120 |
| Braeburn Inc. | 5 | $98 |
Products named: REPATHA, NURTEC ODT, FARXIGA, TRELEGY ELLIPTA, Leqembi, Dexcom G6 Transmitter, KISUNLA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
